Biodegradable bolus methane inhibitor

Slow-release, biodegradable capsule placed in the animal’s rumen that can reduce methane production by 70% for up to six months.

Gloved hand holding a white medical capsule container against blue background
Courtesy of Ruminant Biotech, featuring the EMITLESS bolus.

Priorities for scaling

high-risk pilotingcatalysing development

This slow-release capsule, designed for placement in the animal’s rumen, administers a steady dose of tribromomethane—a synthetic compound inspired by the methane-inhibiting properties of seaweed. By targeting key enzymes in the methanogenesis process in the rumen, the bolus effectively blocks methane production for up to six months. Its biodegradable nature eliminates retrieval requirements, and is predicted to be economically viable delivering a enteric methane reduction of at least 70%.

This innovation is particularly suited for pasture-based systems where feed-based methane inhibitors are impractical.

Food System Area

agricultural inputs & primary production practiceswaste

Enteric methane emissions from livestock are a significant source of agricultural greenhouse gases, contributing to climate change. Existing methane reduction strategies, such as feed additives, are not feasible for grazing systems where controlled feeding is difficult. The biodegradable bolus addresses this gap by offering a long-term, practical solution that reduces methane emissions directly at the source while requiring minimal intervention.

Problem area

reducing agricultural footprint

What impact could it have?

What factors influence scaling?

This innovation is bundled with digital farm management tools, including an electronic tracking device that allows farmers to track which livestock have already been treated.

The application is global, with high relevance for countries with extensive pasture-based livestock.

Within this, large-scale farms are expected to adopt this technology initially, with subsidies and technical support enabling uptake among smallholders in the long term.

Low. Due to the slow-release, this innovation offers a minimally disruptive innovation, not needing daily dosage or even application during feeding.

Ruminant BioTech

Potential risks include incomplete degradation of the bolus in certain environmental conditions, safety concerns related to tribromomethane dosing, and potential impacts on rumen microbiota. Ongoing research and monitoring are critical to address these issues.
Gloved hand holding a white medical capsule container against blue background
biodegradable-bolus-methane-inhibitor

Where is acceleration most needed?

Accelerator scores reflect the degree of action needed across eight key accelerators of change that can enable an innovation to scale. A higher score signals that greater effort and support are needed in that area to unlock uptake at scale. Click on each accelerator to see what’s been achieved and what still needs attention.

Building Trust

Medium - High level
Medium - High

Building Trust

Promoting the bolus as a practical and safe and effective alternative to feed-based solutions requires education and demonstration projects to shift farmer perceptions.

Transforming Mindsets

High level
High

Transforming Mindsets

Collaboration with farmers, regulators, and environmental organizations is crucial to ensure broad acceptance and adoption.

Enabling Social License

High level
High

Enabling Social License

Sustained investment from public and private sectors is necessary to support research, regulatory approval, and scaling efforts.

Ensuring Stable Finance

High level
High

Ensuring Stable Finance

Incentives such as subsidies, carbon credits, and recognition in sustainability certifications can drive adoption and scalability.

Designing Market Incentives

Medium level
Medium

Designing Market Incentives

Policies must evolve to recognize and support methane mitigation technologies, ensuring alignment with emissions reduction targets.

Changing Policies and Regulations

Low - Medium level
Low - Medium

Changing Policies and Regulations

There may be a need for some regulation of the market, particularly concerning health and safety standards and animal welfare considerations.

Safeguarding Against Undesirable Effects

High level
High

Safeguarding Against Undesirable Effects

Comprehensive monitoring of tribromomethane’s environmental and health impacts is necessary to ensure the bolus delivers net-positive outcomes.

Developing Transition Pathways

High level
High

Developing Transition Pathways

Clear pathways for adoption, including farmer training, subsidies, and integration with emissions tracking systems, are essential to ensure successful implementation.

Reference

Image: Courtesy of Ruminant Bio Tech, https://ruminantbiotech.com/

 

Methane inhibitor bolus could reduce emissions by 70%. (2022, December 15). Rural News Group. https://www.ruralnewsgroup.co.nz/dairy-news/dairy-farm-health/methane-inhibitor-bolus-could-reduce-emissions-by-70

 

New Zealand Leads Global Charge in Methane Reduction: Insights from the Latest Dairy Innovations. (2024, December 20). The Bullvine. https://www.thebullvine.com/news/new-zealand-leads-global-charge-in-methane-reduction-insights-from-the-latest-dairy-innovations/

 

Scattergood, G. (2024, August 27). AgriZeroNZ invests extra $4m in Kiwi company developing methane-inhibiting bolus. AgTechNavigator. https://www.agtechnavigator.com/Article/2024/08/27/agrizeronz-invests-extra-4m-in-kiwi-company-developing-methane-inhibiting-bolus/

Other Innovations